Daily FNArena News - Australia

Yet another guidance downgrade from Bapcor brings management’s expectation of a second half turnaround into question

NextDC’s contract utilisation and capex update highlights potential to far exceed FY25 numbers

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Collins Foods produced record interim results in a difficult environment, prompting management to issue a ‘conservative’ upgrade to FY26 guidance

Following a surprisingly weak first half, Metcash’s early second half metrics suggest improvement, perhaps signalling a trough, although caution remains

Management at Downer EDI’s Investor Day set targets above consensus forecasts

A meaty sell off in banks, technology large cap stocks dragged down the ASX200 to its worst performance since April, while gold stocks continued to shine

Fisher & Paykel Healthcare’s first half saw lower costs overcoming a drag from US tariffs. Declining US vaccination rates could provide a boost in the second half

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements